Search

Your search keyword '"de Haan, Judith J"' showing total 42 results

Search Constraints

Start Over You searched for: Author "de Haan, Judith J" Remove constraint Author: "de Haan, Judith J"
42 results on '"de Haan, Judith J"'

Search Results

1. CXCL4 drives fibrosis by promoting several key cellular and molecular processes

3. How open science can support the 3Rs and improve animal research.

4. Meaningful public engagement in the context of open science: reflections from early and mid-career academics

6. Meaningful public engagement in the context of open science: reflections of early and mid-career academics

7. Meaningful public engagement in the context of open science: reflections of early and mid-career academics

8. CXCL4 drives fibrosis by promoting several key cellular and molecular processes

12. Open Science Monitor 2020 Utrecht University: Commissioned by the Utrecht University Open Science Programme

13. A 3-year evaluation of preclinicaltrials.eu reveals room for improvement in preregistration of animal studies

14. Open Science Monitor 2020 Utrecht University: Commissioned by the Utrecht University Open Science Programme

15. The transverse aortic constriction heart failure animal model:a systematic review and meta-analysis

16. The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis

17. The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis

19. Corrigendum to: Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure (vol 279, pg 141, 2019)

20. The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular Diseases

21. The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular Diseases

22. Corrigendum to ‘Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure’ [Int. J. Cardiol., Volume 279, 15 March 2019, Pages 141-144]

23. Corrigendum to: Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure (vol 279, pg 141, 2019)

24. Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice

27. Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload

28. Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice

29. Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice

30. Growth differentiation factor 15 is associated with major amputation and mortality in patients with peripheral artery disease

31. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

32. Leukocytic toll-like receptor 2 deficiency preserves cardiac function and reduces fibrosis in sustained pressure overload

33. Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice

34. Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice

35. Growth differentiation factor 15 is associated with major amputation and mortality in patients with peripheral artery disease

36. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

37. Leukocytic toll-like receptor 2 deficiency preserves cardiac function and reduces fibrosis in sustained pressure overload

38. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

39. Endogenous tissue transglutaminase critically regulates cardiac remodeling through distinct enzymatic and non‐enzymatic actions

42. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.

Catalog

Books, media, physical & digital resources